Article · 31 Mar 2025
Research articlePublished 2013
Treatment Outcomes of Chemoradiotherapy for Patients with Advanced Esophageal Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: To evaluate the treatment outcomes of chemoradiotherapy for patients with advanced esophageal cancer and estimate the prognostic factors. Materials and methods: Patients with advanced esophageal cancer, who were treated with chemoradiotherapy (CRT) between April 2003 and December 2010, were evaluated. Patients received concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil and 61.2 Gy radiotherapy). Therapeutic response, overall survival time, and toxicity were examined and statistical evaluation was performed. Results: One hundred and fourteen patients were treated with CRT. Among them, 84 patients (77.2%) received the complete course of CRT. Eighteen patients (15.8%) had a complete response, 90 patients (78.9%) had a partial response and 6 patients (5.3%) exhibited progressive disease. The mean follow-up period was 14.6 months (range, 2-90 months). The median overall survival time was 13.0 months. The 2-year and 3-year overall survival rates were 38.1% and 19.2%, respectively. Severe hematological toxicities included Grade 3 leukopenia in 40 patients (35.1%). Treatment-related death was estimated to have occurred in 7 patients. Performance status and body weight loss were identified as significant prognostic factors. Conclusion: In our study, PS and body weight loss showed prognostic factors in CRT for advanced esophageal cancer.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2015
Influence of Prognostic Factors on Survival in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Combination of Chemoradiotherapy
Research article · 2016
Prognostic Value of 18F-FDG PET/CT Metabolic Tumor Volume for Complete Pathologic Response and Clinical Outcomes after Neoadjuvant Chemoradiation Therapy for Locally Advanced Esophageal Cancer
Research article · 2015
Pre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal Tumors
Case report · 2013
Gamma Knife and Chemoradiotherapy Applied Nasopharyngeal Cancer Patient Observed Radiation-Induced Optic Neuropathy and Retinopathy: A Case Report
More from this journal
The newest in Nuclear Medicine & Radiation Therapy.
Opinion · 1 Dec 2025
Radiolabeled Antibody Conjugates: Targeting Cancer Resistance
Brief report · 1 Dec 2025
AI: Precision Radionuclide Therapy Dosimetry Advancements
Brief report · 1 Dec 2025
Multi-Isotope Therapy: Powering Precision Nuclear Oncology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNuclear Medicine & Radiation Therapy
- SubjectRadiology & Imaging
- SubjectEnergy & Power
- BylineArticles whose byline prints “Akira Anbai”
- BylineArticles whose byline prints “Makoto Koga”
- BylineArticles whose byline prints “Manabu Hashimoto”

